Bio Essence Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.138511 million compared to USD 0.235927 million a year ago. Revenue was USD 0.288136 million compared to USD 0.235927 million a year ago. Net loss was USD 0.164193 million compared to USD 0.163538 million a year ago.
For the six months, sales was USD 0.32009 million compared to USD 0.447955 million a year ago. Revenue was USD 0.59455 million compared to USD 0.447955 million a year ago. Net loss was USD 0.397315 million compared to USD 0.373893 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.